🇺🇸 FDA
Patent

US 10905683

Compositions and uses of amidine derivatives

granted A61KA61K31/4418A61K9/0053

Quick answer

US patent 10905683 (Compositions and uses of amidine derivatives) held by BioCryst Pharmaceuticals, Inc. expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/4418, A61K9/0053, A61K9/0095, A61K9/4858